Doctor Anywhere (DA), a regional tech-led healthcare company  headquartered in Singapore, announced today that it has raised its Series C financing round, led by growth  equity investor Asia Partners. The round also attracted other investors including Novo Holdings, Philips  and OSK-SBI Venture Partners.

At $88 million SGD (US$65.7 million), it is one of the largest private funding rounds ever raised by a  healthtech company in Southeast Asia. 

Existing investors also participated in the round, including Singapore-based global investor EDBI, Square  Peg, IHH Healthcare, Kamet Capital and Pavilion Capital. This round brings the total capital raised by  Doctor Anywhere since founding to more than $140 million SGD. 

As a result of the financing, Oliver Rippel, Co-Founder and Partner of Asia Partners, and Dr Amit Kakar,  Senior Partner, Head of Novo Holdings Equity Asia will come onboard DA’s Board of Directors. 

Since its launch in 2017, DA has grown exponentially to serve more than 1.5 million users across Southeast  Asia. Over the past 18 months, the COVID-19 pandemic has also served as a catalyst to fast-track the  adoption of telehealth services in the region, an innovation which enabled the healthcare industry to  continue providing high-quality, affordable care to families through the crisis. 

Lim Wai Mun, founder and CEO of Doctor Anywhere

Lim Wai Mun, founder and CEO of Doctor Anywhere, said: “DA’s mission is to be the largest tech-enabled  omnichannel healthcare provider in Southeast Asia, and applying innovative technology to improving  patient outcomes is core to our differentiated offerings. We are thrilled to attract the interest of a strong  group of investors in this round, a significant milestone which is a testament to our vision and track record.” 

DA has built a strong ecosystem of payers, providers, and patients across its core markets. It has close to  2800 doctors and medical professionals within its network in the region, and it also works closely with major hospitals and healthcare institutions. 

This latest investment will significantly bolster DA’s market leadership and put the group in a leading  position to further deepen its presence in its existing markets. It will also allow the group to expand into  new markets, to drive its mission of transforming the regional healthcare landscape through technology.

“We will utilize this funding to further enhance our digital capabilities, and scale up on our ability to deliver  quality healthcare seamlessly to our users in Southeast Asia,” added Lim. 

“We are deeply impressed by what Wai Mun and his team have accomplished in such a short period of  time,” said Oliver M. Rippel, a co-founder of Asia Partners. “As our region’s leading omnichannel  healthcare innovator, DA is helping the healthcare industry rise to the occasion for the challenges and  opportunities in the decade ahead. We are proud to be partnering with DA to support its continued  growth.” 

Kien T. Nguyen, a co-founder of Asia Partners, added, “DA is becoming a true regional leader in  omnichannel healthcare, following the proven regionalization playbook of Southeast Asia’s first  generation of internet platform companies. The powerful combination of telehealth and offline care is  deeply compelling to payers, providers, and patients across our region of 650 million people, and DA is leading the way.” 

Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia, said: “We are very pleased to invest in  DA and to support its mission to transform the regional healthcare landscape through technology. The  pandemic accelerated a trend that was already gaining traction – the delivery of high quality, cost effective  and highly accessible healthcare through digital means, regardless of where the patients are located. DA  offers a leading approach to combining the online and offline realms of healthcare through an  omnichannel strategy, bringing the delivery of patient care to the next level of tech-led healthcare. We  look forward to leveraging this momentum and continuing to work with Wai Mun and his team, true  leaders in this space.” 

Doctor Anywhere is currently available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines.  The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho  Chi Minh City, Vietnam. 

About Doctor Anywhere

Doctor Anywhere is a regional tech-enabled, omnichannel healthcare company, on a mission to make  healthcare simple, accessible, and efficient for everyone. Doctor Anywhere’s digital platform bridges gaps  in the healthcare ecosystem through technology and innovation, enabling users to manage their health  easily and effectively through the DA mobile app. Headquartered in Singapore and with a presence in six  countries across the region, Doctor Anywhere now serves more than 1.5 million (and growing) users  across Southeast Asia.